Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qin Sun
Observed name:
Q R Sun
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Zhejiang University
ORCID:
0000-0001-7499-2055
Observed ORCID:
0000-0001-7499-2055
OpenAlex ID:
A5045724501
Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
2024
·
Mohamed Elmeliegy
, Joseph Chen
, et al.
·
Clinical Pharmacology & Therapeutics
·
26
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
2025
·
Ting Wang
, Yow‐Ming Wang
, et al.
·
Clinical Pharmacology & Therapeutics
·
10
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ ‐1a Biologics to Inform Potential Utility in Biosimilar Development
2025
·
Lakshmi Manasa S. Chekka
, Deepti P. Samarth
, et al.
·
Clinical Pharmacology & Therapeutics
·
4
[Clinical application and critical thinking of the 5th WHO classification of renal cell carcinoma].
2023
·
C Lai
, Q R Sun
, et al.
·
PubMed
·
2
Quantitative Study on the Location Selection of a Subsea Isolation Valve of Deep Water Riser
2018
·
Qin Sun
·
The Twenty-fifth International Ocean and Polar Engineering Conference
·
1
Biosimilar Development Considerations for Therapeutic Proteins With Limited Systemic Exposure: A Landscape Analysis and Pathway Evaluation
2026
·
Ting Wang
, Jenny Zheng
, et al.
·
Clinical Pharmacology & Therapeutics
PDF
Show more works
View as search
Works count:
6
Citation count:
43
H-index:
3
I10-index:
2
Year
Topic
Type